查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413507

皮膚癌皮膚科市場：按測試項目、年齡層、設施類型分類 - 全球預測 2024-2030

Skin Cancer Dermatology Market by Test (Dermatoscopy, Diagnostic Imaging, Lymph Node Biopsy), Age Group (0-19, 20-39, 40-59), Facility Type - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年皮膚癌皮膚科市場規模為77.8億美元，2024年達84.2億美元，預計2030年將達到128.3億美元，複合年成長率為7.40%。

全球皮膚癌皮膚科市場

主要市場統計
基準年[2023] 77.8億美元
預測年份 [2024] 84.2億美元
預測年份 [2030] 128.3億美元
複合年成長率（%） 7.4%
皮膚癌皮膚科市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估皮膚癌皮膚科市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對皮膚癌皮膚病學市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-皮膚癌皮膚科市場的市場規模和預測是多少？

2-在皮膚癌皮膚科市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-皮膚癌皮膚科市場的技術趨勢和法律規範是什麼？

4-皮膚癌皮膚科市場主要供應商的市場佔有率是多少？

5-進入皮膚癌皮膚科市場適合的型態和策略手段有哪些？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球皮膚癌發生率上升
      • 先進醫療基礎設施的可用性
      • 提高大眾對皮膚癌的認知
    • 抑制因素
      • 資本集中治療
    • 機會
      • 透過引入遠距皮膚病學繼續發展
      • 與智慧型手機相容的診斷設備的數量正在增加。
    • 任務
      • 嚴格的核准和處理法規結構
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章皮膚癌皮膚科市場測試

  • 皮膚鏡檢查
  • 診斷影像
  • 淋巴結活體組織切片
  • 皮膚切片檢查

第7章皮膚癌皮膚科市場：依年齡層

  • 0-19
  • 20-39
  • 40-59
  • 60-64
  • 65-74
  • 75-84
  • 85及以上

第8章按設施類型分類的皮膚癌皮膚科市場

  • 皮膚科組
  • 醫院OPD
  • 多專科診所
  • 獨立練習

第9章北美和南美皮膚癌皮膚科市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太皮膚癌皮膚科市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲皮膚癌皮膚科市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Amgen, Inc.
    • Bristol-Myers Squibb Company
    • Canfield Scientific, Inc.
    • Colleyville Dermatology
    • Cutera, Inc.
    • FotoFinder Systems, Inc.
    • Merck & Co., Inc.
    • MetaOptima Technology Inc.
    • Novartis AG
    • Pfizer Inc.
    • Regeneron Pharmaceuticals, Inc.
    • Sanofi SA
    • Skin Analytics Pty Ltd.
    • Speclipse, Inc.
    • Sun Pharmaceutical Industries Limited
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-0360AB17E10E

[190 Pages Report] The Skin Cancer Dermatology Market size was estimated at USD 7.78 billion in 2023 and expected to reach USD 8.42 billion in 2024, at a CAGR 7.40% to reach USD 12.83 billion by 2030.

Global Skin Cancer Dermatology Market

KEY MARKET STATISTICS
Base Year [2023] USD 7.78 billion
Estimated Year [2024] USD 8.42 billion
Forecast Year [2030] USD 12.83 billion
CAGR (%) 7.4%
Skin Cancer Dermatology Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Skin Cancer Dermatology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Skin Cancer Dermatology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Skin Cancer Dermatology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen, Inc., Bristol-Myers Squibb Company, Canfield Scientific, Inc., Colleyville Dermatology, Cutera, Inc., FotoFinder Systems, Inc., Merck & Co., Inc., MetaOptima Technology Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Skin Analytics Pty Ltd., Speclipse, Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Skin Cancer Dermatology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test
    • Dermatoscopy
    • Diagnostic Imaging
    • Lymph Node Biopsy
    • Skin Biopsy
  • Age Group
    • 0-19
    • 20-39
    • 40-59
    • 60-64
    • 65-74
    • 75-84
    • 85 & Above
  • Facility Type
    • Dermatology Group
    • Hospital OPD
    • Multispecialty Clinics
    • Stand Alone Practices
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Skin Cancer Dermatology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Skin Cancer Dermatology Market?

3. What are the technology trends and regulatory frameworks in the Skin Cancer Dermatology Market?

4. What is the market share of the leading vendors in the Skin Cancer Dermatology Market?

5. Which modes and strategic moves are suitable for entering the Skin Cancer Dermatology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Skin Cancer Dermatology Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of skin cancer worldwide
      • 5.1.1.2. Availability of advanced healthcare infrastructure
      • 5.1.1.3. Rising awareness about skin cancer among the population
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive treatment with therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development with introduction of teledermatology
      • 5.1.3.2. Increasing number of smartphone-compatible diagnostic devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory framework for the approval and treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Skin Cancer Dermatology Market, by Test

  • 6.1. Introduction
  • 6.2. Dermatoscopy
  • 6.3. Diagnostic Imaging
  • 6.4. Lymph Node Biopsy
  • 6.5. Skin Biopsy

7. Skin Cancer Dermatology Market, by Age Group

  • 7.1. Introduction
  • 7.2. 0-19
  • 7.3. 20-39
  • 7.4. 40-59
  • 7.5. 60-64
  • 7.6. 65-74
  • 7.7. 75-84
  • 7.8. 85 & Above

8. Skin Cancer Dermatology Market, by Facility Type

  • 8.1. Introduction
  • 8.2. Dermatology Group
  • 8.3. Hospital OPD
  • 8.4. Multispecialty Clinics
  • 8.5. Stand Alone Practices

9. Americas Skin Cancer Dermatology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Skin Cancer Dermatology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Skin Cancer Dermatology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Amgen, Inc.
    • 13.1.3. Bristol-Myers Squibb Company
    • 13.1.4. Canfield Scientific, Inc.
    • 13.1.5. Colleyville Dermatology
    • 13.1.6. Cutera, Inc.
    • 13.1.7. FotoFinder Systems, Inc.
    • 13.1.8. Merck & Co., Inc.
    • 13.1.9. MetaOptima Technology Inc.
    • 13.1.10. Novartis AG
    • 13.1.11. Pfizer Inc.
    • 13.1.12. Regeneron Pharmaceuticals, Inc.
    • 13.1.13. Sanofi S.A.
    • 13.1.14. Skin Analytics Pty Ltd.
    • 13.1.15. Speclipse, Inc.
    • 13.1.16. Sun Pharmaceutical Industries Limited
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. SKIN CANCER DERMATOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SKIN CANCER DERMATOLOGY MARKET DYNAMICS
  • FIGURE 7. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 8. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2030 (%)
  • FIGURE 12. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. SKIN CANCER DERMATOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 6. SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SKIN CANCER DERMATOLOGY MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SKIN CANCER DERMATOLOGY MARKET SIZE, BY LYMPH NODE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SKIN CANCER DERMATOLOGY MARKET SIZE, BY SKIN BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 11. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 0-19, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 20-39, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 40-59, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 60-64, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 65-74, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 75-84, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. SKIN CANCER DERMATOLOGY MARKET SIZE, BY 85 & ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY GROUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL OPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. SKIN CANCER DERMATOLOGY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. SKIN CANCER DERMATOLOGY MARKET SIZE, BY STAND ALONE PRACTICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY FACILITY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 151. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. SKIN CANCER DERMATOLOGY MARKET LICENSE & PRICING